Mason W. Freeman

Mason W. Freeman

Director Técnico/Científico/I+D en CINCOR PHARMA, INC. .
75 años
Health Technology
Consumer Services
Health Services

Perfil

Mason W.
Freeman
is currently the Director of Translational Medicine at The General Hospital Corp.
He is also a Venture Partner at 5AM Venture Management LLC and a Professor at Harvard Medical School.
Additionally, he holds the position of Chief Medical Officer at CinCor Pharma, Inc. starting in 2022.
In his former roles, Dr. Freeman served as a Director at Envoy Therapeutics, Inc. and Mitobridge, Inc. He was also a Director at scPharmaceuticals, Inc. from 2018 to 2020 and an Independent Director at Crinetics Pharmaceuticals, Inc. from 2015 to 2019.
Prior to that, he was the Head of Translational Medicine at Novartis AG from 2005 to 2007.
Dr. Freeman completed his undergraduate studies at Harvard University and obtained a doctorate degree from the University of California.

Cargos activos de Mason W. Freeman

EmpresasCargoInicio
CINCOR PHARMA, INC. Director Técnico/Científico/I+D 01/03/2022
Corporate Officer/Principal -
Corporate Officer/Principal -
Inversor de Capital Privado 01/01/2008

Antiguos cargos conocidos de Mason W. Freeman.

EmpresasCargoFin
SCPHARMACEUTICALS INC. Director/Miembro de la Junta 01/12/2020
CRINETICS PHARMACEUTICALS, INC. Director/Miembro de la Junta 01/07/2019
Director/Miembro de la Junta 01/01/2018
NOVARTIS AG Corporate Officer/Principal 01/04/2007
Director/Miembro de la Junta -
Ver el detalle de la experiencia de Mason W. Freeman.

Formación de Mason W. Freeman.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

78

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Consumer Services

Health Services

Finance

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Mason W. Freeman
-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN